Upgrade to SI Premium - Free Trial

Biogen Idec, Inc. (BIIB) Tops Q4 EPS by 7c; Issues Weak FY14 Profit Outlook

January 29, 2014 6:32 AM
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q4 EPS of $2.34, $0.07 better than the analyst estimate of $2.27. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Corp. News Hot Earnings Hot Guidance Hot List

Next Articles